AVT001

Avotres Inc. · Phase 1 active Small molecule

At a glance

Generic name	AVT001
Sponsor	Avotres Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

AVT001 CI brief — competitive landscape report
AVT001 updates RSS · CI watch RSS
Avotres Inc. portfolio CI